Pharmacy Blogs

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … MarketWatch (press release) Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for … and more »

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … – MarketWatch (press release)

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … MarketWatch (press release) Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for … and more »

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … – MarketWatch (press release)

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston … MarketWatch (press release) As a result of the merger, Ariston became a wholly owned subsidiary of Manhattan Pharmaceuticals. Under the terms of the merger agreement, … and more »

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston … – MarketWatch (press release)

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston … MarketWatch (press release) As a result of the merger, Ariston became a wholly owned subsidiary of Manhattan Pharmaceuticals. Under the terms of the merger agreement, … and more »

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston … – MarketWatch (press release)

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … MarketWatch (press release) Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for … and more »

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … – MarketWatch (press release)

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston … MarketWatch (press release) As a result of the merger, Ariston became a wholly owned subsidiary of Manhattan Pharmaceuticals. Under the terms of the merger agreement, … and more »

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston … – MarketWatch (press release)

Endo names ex-Nora Therapeutics CEO as COO The Associated Press Endo Pharmaceuticals is a specialty pharmaceutical company involved with drugs used to treat and manage pain, prostate cancer and the early onset of puberty … Endo Pharmaceuticals Announces Appointment of New Chief Operating OfficerPR Newswire (press release) all 106 news articles »

Endo names ex-Nora Therapeutics CEO as COO – The Associated Press

Endo names ex-Nora Therapeutics CEO as COO The Associated Press Endo Pharmaceuticals is a specialty pharmaceutical company involved with drugs used to treat and manage pain, prostate cancer and the early onset of puberty … Endo Pharmaceuticals Announces Appointment of New Chief Operating OfficerPR Newswire (press release) all 106 news articles »

Endo names ex-Nora Therapeutics CEO as COO – The Associated Press

Endo names ex-Nora Therapeutics CEO as COO The Associated Press Endo Pharmaceuticals is a specialty pharmaceutical company involved with drugs used to treat and manage pain, prostate cancer and the early onset of puberty … Endo Pharmaceuticals Announces Appointment of New Chief Operating OfficerPR Newswire (press release) all 106 news articles »

Endo names ex-Nora Therapeutics CEO as COO – The Associated Press

Times Online

Torrent Pharmaceuticals signs license agreement with AstraZeneca Stock Watch Torrent Pharmaceuticals has singed a supply and licensing agreement with the UK based drug maker AstraZeneca. AstraZeneca, a $32.8-billion enterprise, … AstraZeneca ties up with Indian drugmakerFinancial Times AstraZeneca teams with generic firmThe News Journal The Next Big Opportunity for Big Pharma Is BRICMinyanville.com NASDAQ -Calcutta Telegraph -domain-B all 159 news articles »

Torrent Pharmaceuticals signs license agreement with AstraZeneca – Stock Watch